SILVER SPRING, Md., Feb. 29, 2012 /PRNewswire/ — Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the “Company” or “Sunpeaks Ventures”) is pleased to announce that it has completed the acquisition of Healthcare Distribution Specialists LLC (“HDS”), a value-added distributor of hard-to-find and specialty drugs. In addition to its drug distribution business, HDS also owns and markets Clotamin, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin, a popular blood thinner that has a long list of known adverse drug and food interactions.

“We are very excited to have completed the transaction to acquire HDS and enter the hard-to-find and specialty drug distribution sector,” stated Mr. Mackie Barch, President and CEO of Sunpeaks Ventures. “We expect to gain significant traction going forward as we work to grow awareness of Clotamin and expand our role as special purchasing agent and procurement expediter for our many distribution customers.”

In addition, the Company is also pleased to announce the engagement of Anslow & Jaclin, LLP as its lead legal counsel. Anslow & Jaclin offers advice and counsel to diverse clients worldwide on unique and sophisticated corporate and securities transactions, reverse mergers, self-filings, PIPEs, corporate finance, and mergers and acquisitions. Anslow & Jaclin is one of a handful of law firms consistently ranked in the top 10 overall by number of PIPE transactions in Deal Flow Media’s publication “The PIPEs Report”.

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market.

For additional information, please visit www.sunpeaksventures.com

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “forecast”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures’ actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures’ filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

SOURCE Sunpeaks Ventures, Inc.